Steve Reed is IDRI's President, CEO & Founder. His academic appointments include Professor of Medicine at Cornell University Medical College in New York and Research Professor of Pathobiology at the University of Washington. He serves on several editorial review committees, has served as a member of the Tropical Medicine Review Board of the National Institutes of Health, and has served as a member of diagnostic and vaccine steering committees of the World Health Organization.
ter Braak (Biometris, Wageningen University and Research Centre, Wageningen, The Netherlands); Mary Ann Huntley (Cornell University); Petr Smilauer (University of South Bohemia, Czech Republic); Maria Terrell (Cornell University)
Without examples to back up honors thesis cornell your analysis
Malcolm received his training through a BSc (Hons) Immunology from the University of Glasgow, Scotland, and a Ph.D. in Medical Microbiology from the University of Edinburgh, Scotland. He then conducted postdoctoral work at the University of Washington where he examined protective and pathologic immune responses during experimental infection. He now works with an extensive network of collaborators in several countries to identify vaccine candidates and develop new diagnostic tools to improve the control of neglected tropical diseases, with particular focus on leprosy and leishmaniasis.
Morten Christiansen; Morten Christiansen
At IDRI, Erik is the Director, GMP (Good Manufacturing Practice) Operations. Previous to IDRI, he was with CMC Biologics from 2005-2010 and at NeoRx, Seattle, for the preceding 5 years as Sr. Director, Manufacturing, and Director of Operations with responsibilities for radio pharmaceutical production, biopharmaceutical pilot manufacturing and contract manufacturing activities. Previously Erik held leadership positions in development and operations at ZymoGenetics in Seattle. He received his MS in Biochemical Engineering from the Technical University of Denmark.
Melissa Kaplan's Herp Care Collection Last updated January 1, 2014
Eduard earned his BA in Biochemistry and Molecular Biology from Franklin & Marshall College and his PhD in Biochemistry and Structural Biology from Stony Brook University. His doctoral work with Dr. Peter J. Tonge focused on elucidating the mechanism of GFP chromophore maturation using protein semi-synthesis. He went on to a postdoctoral position with Dr. Iwao Ojima evaluating anti-tubercular compound series that inhibit the cell division protein FtsZ and screening computationally designed small molecule inhibitors of Botulinum neurotoxin.
Statement and Press — Ellen Jewett Sculpture
Doug received his PhD in molecular, cellular and developmental biology from the University of Colorado at Boulder, and did postdoctoral research in plant genetic engineering at the Plant Breeding Institute in Cambridge England. Doug received his JD (with honors) from the University of Washington. Prior to going to law school, Doug was a Research Assistant Professor at the University of Washington in the Department of Botany.
Speakers - Molecular Med Tri-Con 2018
Anna Marie Beckmann earned her PhD from the Department of Immunology and Infectious Diseases at Johns Hopkins University School of Public Health. Her thesis was focused on the pathobiology of infection with the human papillomaviruses JC and BK.